Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

Toy M, Önder FO, Wörmann T, Bozdayi AM, Schalm SW, Borsboom GJ, van Rosmalen J, Richardus JH, Yurdaydin C (2011)
BMC infectious diseases 11(1): 337.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Toy, Mehlika; Önder, Fatih Oguz; Wörmann, TanjaUniBi; Bozdayi, A Mithat; Schalm, Solko W; Borsboom, Gerard J; van Rosmalen, Joost; Richardus, Jan Hendrik; Yurdaydin, Cihan
Einrichtung
Fakultät für Gesundheitswissenschaften
Abstract / Bemerkung
BACKGROUND: To provide a clear picture of the current hepatitis B situation, the authors performed a systematic review to estimate the age- and region-specific prevalence of chronic hepatitis B (CHB) in Turkey. METHODS: A total of 339 studies with original data on the prevalence of hepatitis B surface antigen (HBsAg) in Turkey and published between 1999 and 2009 were identified through a search of electronic databases, by reviewing citations, and by writing to authors. After a critical assessment, the authors included 129 studies, divided into categories: 'age-specific'; 'region-specific'; and 'specific population group'. To account for the differences among the studies, a generalized linear mixed model was used to estimate the overall prevalence across all age groups and regions. For specific population groups, the authors calculated the weighted mean prevalence. RESULTS: The estimated overall population prevalence was 4.57, 95% confidence interval (CI): 3.58, 5.76, and the estimated total number of CHB cases was about 3.3 million. The outcomes of the age-specific groups varied from 2.84, (95% CI: 2.60, 3.10) for the 0-14-year olds to 6.36 (95% CI: 5.83, 6.90) in the 25-34-year-old group. CONCLUSION: There are large age-group and regional differences in CHB prevalence in Turkey, where CHB remains a serious health problem.
Erscheinungsjahr
2011
Zeitschriftentitel
BMC infectious diseases
Band
11
Ausgabe
1
Art.-Nr.
337
ISSN
1471-2334
Page URI
https://pub.uni-bielefeld.de/record/2476406

Zitieren

Toy M, Önder FO, Wörmann T, et al. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC infectious diseases. 2011;11(1): 337.
Toy, M., Önder, F. O., Wörmann, T., Bozdayi, A. M., Schalm, S. W., Borsboom, G. J., van Rosmalen, J., et al. (2011). Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC infectious diseases, 11(1), 337. doi:10.1186/1471-2334-11-337
Toy, Mehlika, Önder, Fatih Oguz, Wörmann, Tanja, Bozdayi, A Mithat, Schalm, Solko W, Borsboom, Gerard J, van Rosmalen, Joost, Richardus, Jan Hendrik, and Yurdaydin, Cihan. 2011. “Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review”. BMC infectious diseases 11 (1): 337.
Toy, M., Önder, F. O., Wörmann, T., Bozdayi, A. M., Schalm, S. W., Borsboom, G. J., van Rosmalen, J., Richardus, J. H., and Yurdaydin, C. (2011). Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC infectious diseases 11:337.
Toy, M., et al., 2011. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC infectious diseases, 11(1): 337.
M. Toy, et al., “Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review”, BMC infectious diseases, vol. 11, 2011, : 337.
Toy, M., Önder, F.O., Wörmann, T., Bozdayi, A.M., Schalm, S.W., Borsboom, G.J., van Rosmalen, J., Richardus, J.H., Yurdaydin, C.: Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC infectious diseases. 11, : 337 (2011).
Toy, Mehlika, Önder, Fatih Oguz, Wörmann, Tanja, Bozdayi, A Mithat, Schalm, Solko W, Borsboom, Gerard J, van Rosmalen, Joost, Richardus, Jan Hendrik, and Yurdaydin, Cihan. “Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review”. BMC infectious diseases 11.1 (2011): 337.

21 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening.
Koc ÖM, Hens N, Bielen R, Van Damme P, Robaeys G., Medicine (Baltimore) 98(18), 2019
PMID: 31045797
Epidemiology of Chronic Hepatitis B in Turkey.
Özkan H., Euroasian J Hepatogastroenterol 8(1), 2018
PMID: 29963468
The impact of economic and social factors on the prevalence of hepatitis B in Turkey.
Tosun S, Aygün O, Özdemir HÖ, Korkmaz E, Özdemir D., BMC Public Health 18(1), 2018
PMID: 29789002
Infectious disease testing of UK-bound refugees: a population-based, cross-sectional study.
Crawshaw AF, Pareek M, Were J, Schillinger S, Gorbacheva O, Wickramage KP, Mandal S, Delpech V, Gill N, Kirkbride H, Zenner D., BMC Med 16(1), 2018
PMID: 30149810
Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
Karabaev BB, Beisheeva NJ, Satybaldieva AB, Ismailova AD, Pessler F, Akmatov MK., Infect Dis Poverty 6(1), 2017
PMID: 28222792
Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B?
Karacaer Z, Okur G, Cermik H, Altun D., Postgrad Med 128(7), 2016
PMID: 27499150
Hepatitis B virus infection in children.
Komatsu H, Inui A., Expert Rev Anti Infect Ther 13(4), 2015
PMID: 25724218
Aflatoxin levels in chronic hepatitis B patients with cirrhosis or hepatocellular carcinoma in Balıkesir, Turkey.
Aydın M, Aydın S, Bacanlı M, Başaran N., J Viral Hepat 22(11), 2015
PMID: 25894298
Evaluation of Potential Donors in Living Donor Liver Transplantation.
Dirican A, Baskiran A, Dogan M, Ates M, Soyer V, Sarici B, Ozdemir F, Polat Y, Yilmaz S., Transplant Proc 47(5), 2015
PMID: 26093708
Seroprevalence of Hepatitis A Virus Antibodies among the Patients with Chronic Hepatitis B in Turkey.
Tulek N, Ozsoy M, Moroglu C, Cagla Sonmezer M, Temocin F, Tuncer Ertem G, Sebnem Erdinc F., Euroasian J Hepatogastroenterol 5(2), 2015
PMID: 29201701
Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study.
Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, Kaymakoglu S, Ergonul O., Clin Microbiol Infect 21(11), 2015
PMID: 26163105
Serological test results of sexually transmitted diseases in patients with condyloma acuminata.
Ünal E, Gönül M, Çakmak S, Yalçınkaya Iyidal A, Kılıç A, Gül Ü, Doner P., Postepy Dermatol Alergol 32(4), 2015
PMID: 26366153
Missed opportunities for Hepatitis B vaccination among diabetic patients.
Ozisik L, Tanriover MD, Calik Basaran N, Oz SG, Unal S., Hum Vaccin Immunother 11(12), 2015
PMID: 26366628
Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey.
Kockaya G, Kose A, Yenilmez FB, Ozdemir O, Kucuksayrac E., Cost Eff Resour Alloc 13(), 2015
PMID: 26664289
Higher seroprevalence of hepatitis B virus antigen in patients with cystic hydatid disease than in patients referred to internal medicine clinics in Turkey.
Gültepe B, Dülger AC, Gültepe İ, Karadas S, Ebinç S, Esen R., Korean J Parasitol 52(1), 2014
PMID: 24623881
Age specific prevalence of hepatitis B and hepatitis C among pregnant women in the northwestern region of Turkey.
Simavli S, Ozlu T, Kucukbayrak B., Indian J Gastroenterol 33(3), 2014
PMID: 24048677
Epidemiology of hepatitis B in the reproductive-age female farmworkers of southeastern Turkey.
Yentur Doni N, Simsek Z, Keklik Z, Gurses G, Zeyrek FY., Hepat Mon 14(11), 2014
PMID: 25598790
Isolated anti-HBc among HIV-infected patients in Istanbul, Turkey.
Karaosmanoglu HK, Aydin OA, Nazlican O., HIV Clin Trials 14(1), 2013
PMID: 23372111
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C.
Efe C, Wahlin S, Ozaslan E, Purnak T, Muratori L, Quarneti C, Tatar G, Simsek H, Muratori P, Schiano TD., Scand J Gastroenterol 48(4), 2013
PMID: 23448312
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
Hahné SJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Laar Mv., BMC Infect Dis 13(), 2013
PMID: 23597411
Leading infectious diseases problems in Turkey.
Erdem H, Akova M., Clin Microbiol Infect 18(11), 2012
PMID: 23043613

97 References

Daten bereitgestellt von Europe PubMed Central.

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.
Lavanchy D., J. Viral Hepat. 11(2), 2004
PMID: 14996343
Update on diagnosis, management, and prevention of hepatitis B virus infection.
Mahoney FJ., Clin. Microbiol. Rev. 12(2), 1999
PMID: 10194463
The epidemiology of viral hepatitis in Turkey: analysis of published data
AUTHOR UNKNOWN, 2007
Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey.
Gurol E, Saban C, Oral O, Cigdem A, Armagan A., Eur. J. Epidemiol. 21(4), 2006
PMID: 16685581
Seroepidemiology of hepatitis B virus infection in children in the Eastern Anatolia
AUTHOR UNKNOWN, 2001
Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK, Toy M, Hahne SJ, De Wit GA, Schalm SW, de Man RA, Richardus JH., Gastroenterology 138(2), 2009
PMID: 19879275
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB., JAMA 283(15), 2000
PMID: 10789670
Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review.
Mohan A, Chandra S, Agarwal D, Guleria R, Broor S, Gaur B, Pandey RM., Respirology 15(3), 2010
PMID: 20415983
Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review.
Chiquete E, Panduro A., Intervirology 50(1), 2006
PMID: 17164551
A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review.
Roman S, Panduro A, Aguilar-Gutierrez Y, Maldonado M, Vazquez-Vandyck M, Martinez-Lopez E, Ruiz-Madrigal B, Hernandez-Nazara Z., Hepatol Int 3(2), 2008
PMID: 19669360
Metan: an alternative meta analysis command
AUTHOR UNKNOWN, 1998
Ankara Bölgesinde Sağlıklı Bireylerde HAV, HBV, ve HCV seroprevalansının yaş ve cinsiyetlere göre dağılımı (Age and gender specific distribution HBV and HCV seroprevalence in healthy individuals in Ankara)
AUTHOR UNKNOWN, 2003
Şırnaktaki asker ve sivillerde asemptomatik HBV taşıyıcılığı prevalansı (Prevalance of inactive HBV disease in soldiers and civilians in Şırnak)
AUTHOR UNKNOWN, 2000
Düzce İlkokullarında hepatit B prevalansı (Hepatitis B prevalence in primary schools in Duzce)
AUTHOR UNKNOWN, 2001
Çocuklarda hepatit A, B ve C virusları seromarker sonuçları (Seroprevalence of hepatitis A, B and C in children)
AUTHOR UNKNOWN, 2000
Van yöresindeki çocuklarda hepatit B infeksiyonu prevalansı (Prevalance of hepatitis B infeciton in children in Van)
AUTHOR UNKNOWN, 2000
Horizontal transmission of HBV infection among students in Turkey.
Degertekin H, Tuzcu A, Yalcin K., Public Health 114(5), 2000
PMID: 11035467
The Face-to-Face Light Detection Paradigm: A New Methodology for Investigating Visuospatial Attention Across Different Face Regions in Live Face-to-Face Communication Settings.
Thompson LA, Malloy DM, Cone JM, Hendrickson DL., g 11(2), 2010
PMID: 21113354
0-6 yaş grubunda hepatit A, B, C, D virus enfeksiyonlarının prevalansının saptanması (Detection of seroprevalance of hepatitis A, B, C and D infections in 0-6 years old)
AUTHOR UNKNOWN, 2000
Sero-epidemiology of hepatitis B infection in an urban paediatric population in Turkey.
Ertekin V, Selimoglu MA, Altinkaynak S., Public Health 117(1), 2003
PMID: 12802905
Hepatit B enfeksiyonunun seroepidemiolojik araştırılması (Seroepidemiology of Hepatitis B)
AUTHOR UNKNOWN, 1999
Prevalence of hepatitis B infection among schoolchildren in Southeast Turkey
AUTHOR UNKNOWN, 2009
Kirikkale ilinde cocuklarda hepatit A, B ve C virus seroprevalansi (Hepatitis A, B and C virus prevalence among children in kirklareli province)
AUTHOR UNKNOWN, 2004
Antakya'da preoperatif hastalarda hepatiti A ve B seropozitifligi, yas ve cinsiyete gore dagilim (Hepatitis A and B positivity among pre-operative patients according to age and gender in Antakya)
AUTHOR UNKNOWN, 2005
Sanayide çalışan adolesanlarda viral hepatit A, B ve C seroprevalansı (Seroepidemiology of hepatitis A, B and C in adolescents working in industry)
AUTHOR UNKNOWN, 2000
Adolesan yaş grubu erkek öğrencilerde hepatit B seroepidemiyolojisi ve ilişkili risk faktörleri (Seroepdiemiology of hepatitis B and related risk factors in adolescent male students)
AUTHOR UNKNOWN, 2003
Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas.
Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S., Jpn. J. Infect. Dis. 58(1), 2005
PMID: 15728984
Izmir Ili Lise ogrencilerinde HbsAg seroprevalansi (HBsAg prevalence among highschool students in Izmir)
AUTHOR UNKNOWN, 2007
Selcuk universitesi ogrencilerinde HbsAg ve Anti-HBs prevalansi (HBsAg and anti-HBs prevalence among Selcuk university students)
AUTHOR UNKNOWN, 2003
Adolesan yas grubu erkek ogrencilerde hepatit B seroepidemiolojisi ve iliskili risk faktorleri (Hepatitis B seropepidemiology and risk factors among adolescent male students)
AUTHOR UNKNOWN, 2004
Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study.
Yildirim B, Barut S, Bulut Y, Yenisehirli G, Ozdemir M, Cetin I, Etikan I, Akbas A, Atis O, Ozyurt H, Sahin S., Turk J Gastroenterol 20(1), 2009
PMID: 19330732
Adana ili yarıkırsal alanda yaşayan 10 yaş üzeri kişilerde HBsAg ve anti-HCV prevalansı (HBsAg and anti-HC V seroprevalence in people older tahn 10 years old in suburban area in Adana)
AUTHOR UNKNOWN, 2002
Huzur evinde kalanlarda ve personelinde HBV enfeksiyonu taramasi (HBV infection screening in the elderly home habitants and personel)
AUTHOR UNKNOWN, 2001
Afyon Bölgesi kan dönorlerinde viral enfeksiyon etkenlerinin araştırılması.(Prevalence of viral infections in blood donors in Afyon region)
AUTHOR UNKNOWN, 2001
Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.
Sakarya S, Oncu S, Ozturk B, Oncu S., Saudi Med J 25(8), 2004
PMID: 15322600
Prevalences of transfusion transmissible markers in donors over a 6-year period
AUTHOR UNKNOWN, 2004
İstanbul'da farklı kan merkezlerinden alınan donör kanlarında üç yıllık HBV, HCV ve HIV seroprevalansının oranlarının karşılaştırılması (Comparison of seroprevalence rates of donors applied to several blood banks in İstanbul)
AUTHOR UNKNOWN, 2003
İ.Ü. Cerrahpaşa kan merkezi HBsAg, anti-HCV, anti-HIV ve sifiliz taraması (HBsAg, anti-HCV, anti-HIV and syphilisis screening in Istanbul University Cerrahpasa Blood Bank)
AUTHOR UNKNOWN, 2005
Kan merkezlerinde bakılan donör tarama testlerinin 4 yıllık değerlendirmesi (Evaluation of four years results of donor screenig tests from various blood banks)
AUTHOR UNKNOWN, 2005
Sık kan bağışlayan kan vericilerinde infeksiyon göstergeleri (Infection markers of blood donors)
AUTHOR UNKNOWN, 2003
Ankara Eğitim ve Araştırma Hastanesine Kan Merkezine başvuran donörlerin HBV, HCV, HIV veVDRL (RPR) testlerinin 5 yıllık değerlendirilmesi (Evaluation of HBV, HCV, HIV and VDRL tests of donors applied to Ankara Training and Research Hospital within a 5 year period)
AUTHOR UNKNOWN, 2001
Kan donörlerinde HB veHC seroprevelansı (Seroprevalence of hepatitis B and C in blood donors)
AUTHOR UNKNOWN, 2003
Batı Karadeniz Bölgesi kan donörlerinde HbsAg ve anti-HCV prevalansı (Prevalence of HBsAg and anti-HCV in blood donors in western Black Sea region of Turkey)
AUTHOR UNKNOWN, 2002
Samsun Doğum Ve Çocuk Bakımevi Kan İstasyonunda 2002 Yılında Başvuran Donörlerin Kan Grupları Ve Serolojik Sonuçlarının Değerlendirilmesi (Evaluation of blood types and serologic results of donors applied to Samsun Obstetrics and Perinatalogy Hospital Blood Bank)
AUTHOR UNKNOWN, 2003
Cumhuriyet Üni Tıp Fakültesi Kan Merkezi Donör Kanlarının HBsAG, Anti-HCV, Anit-HIV ve sifiliz seropozitifliği yönünden değerlendirlimesi.(Evaluation of seropositivity of HBsAg, anti-HCV, anti-HIV and syphilis of donor blood samples applied to Cumhuriyet University Blood Bank)
AUTHOR UNKNOWN, 2001
Hatay bolgesindeki kan donerlerinde HBV, HCV, HIV ve VDRL seropozitifligi (HBV, HCV, HIV and VDRL seropositivity in blooddonors in Hatay province)
AUTHOR UNKNOWN, 2005
Diyarbakır ilinde kan donörlerinde HbsAg ve anti-HCV prevalansı (Prevalence of HBsAg and Anti-HCV in blood donors in Diyarbakır)
AUTHOR UNKNOWN, 2003
Erzurum yöresindeki kan donörlerinde HbsAg, anti-HCV, anti-HIV ve VDRL(RPR) seroprevalansı (Seroprevalence of HBsAg, anti-HCV, anti-HIV and VDRL(RPR) n blood donors in Erzurum region)
AUTHOR UNKNOWN, 2001
Kan donörlerinde HBV, HCV, HIV ve VDRL seropozitifliği (HBV, HCV, HIV and VDRL seropositivity in blood donors)
AUTHOR UNKNOWN, 2003
Kırıkkale ilinin devlet hastanesi ve Kırıkkale Üniversitesi Tıp Fakültesine Başvuran Hastalarda hepatit B seroprevalansı (Hepatitis B seroprevalence in Kırıkklae Government Hospital and Kırıkkale University Hospital)
AUTHOR UNKNOWN, 2002
Ankara İlinde HBV ve HCV seroprevalansı (HBV and HCV seroprevalence in Ankara)
AUTHOR UNKNOWN, 2003
Mersin ilinde HBsAg, Anti-HBs, anti-HCV ve anti-HDV seroprevalansı (Seroprevalence of HBsAg, anti-HBs, anti-HCV and anti-HDV in Mersin)
AUTHOR UNKNOWN, 2001
Hastanemizde üç yıllık HBV ve HCV markerlarının değerlendirilmesi (Evaluation of HBV and HCV markers of a three years period in our hospital)
AUTHOR UNKNOWN, 2003
Şanlıurfa ilinde HBsAg, Anti-HBs, anti-HCV seroprevalansı (HBsAg, anti-HCV seroprevalence in Şanlıurfa)
AUTHOR UNKNOWN, 2001
Sağlıklı gebelerde HBV, HCV ve HIV seroprevalansı ve risk faktörlerinin belirlenmesi (Prevelance of HBV, HCV and HIV and releted risk factors in pregant women)
AUTHOR UNKNOWN, 2004
Seroprevalence of hepatitis B virus among pregnant women in northern Turkey
AUTHOR UNKNOWN, 2009
Seroprevalence of syphilis, human immunodeficiency virus type-1, and hepatitis B virus infections among pregnant women in Turkey.
Nas T, Taner MZ, Yildiz A., Int J Gynaecol Obstet 66(2), 1999
PMID: 10468342
Prevalence of hepatitis B virus infection in young Turkish men.
Erdem H, Oncu S, Pahsa A., Trop Doct 35(3), 2005
PMID: 16105361
Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus.
Altindis M, Yilmaz S, Dikengil T, Acemoglu H, Hosoglu S., World J. Gastroenterol. 12(42), 2006
PMID: 17106927
Prevalence of hepatitis B virus carriers among soldiers and civilians in Turkey.
Emiroglu HH, Altunay H, Oguz S., J. Clin. Gastroenterol. 38(7), 2004
PMID: 15232371
Askerkerde HBsAg arastirmasi (HBsAg screening in military recruits)
AUTHOR UNKNOWN, 2001
Turk dis hekimlerinde hepatit B gorulme sikligi (Hepatitis B prevalence among Turkish dentists)
AUTHOR UNKNOWN, 1992
Tip ve Dis hekimligi fakultesinin hekim, memur, ve hastane personelinden olusan bir grup calisanlarinda HbsAg'nin ELISA ile arastirilmasi (Measuring HBsAg prevalence in a medical faculty among Medical personnel dentists, and hospital personel using ELISA method)
AUTHOR UNKNOWN, 1993
Turkiye yuksek ihtisas hastanesi saglik personelinde HBV prevalansi (HBV prevalence among Turkiye Yuksek Ihtisas hospital medical personnel)
AUTHOR UNKNOWN, 1994
Acil servis personeli ve HBV enfeksiyonu (HBV infection and emergency department personel)
AUTHOR UNKNOWN, 1995
Yuksek risk grubunda olan saglik calisanlarinda viral hepatit enfeksiyon sikligi (Viral hepatitis infection in the high risk population medical personnel)
AUTHOR UNKNOWN, 1997
Saglik personelinde hepatit B ve C seroprevalansi (Hepatitis B and C prevalence among medical personnel)
AUTHOR UNKNOWN, 1997
Hastane personelinde hepatit B seroprevaleansi ve rekombinant hepatit B asisina imun cevap (Hepatitis B prevalence among hospital personnel and the immuun response to the recombinant hepatitis B vaccination)
AUTHOR UNKNOWN, 1998
Trakya universitesi egitim uygulama ve arastirma hastanesi calisanlarda hepatit B virus enfeksiyonu (Hepatitis B infection among medical personnel in Trakya university hospital)
AUTHOR UNKNOWN, 1999
Bir meslek hastaligi olarak iki ayri hastanede hepatit B taramasi (Hepatitis B screening in two different hospital settings among medical personnel)
AUTHOR UNKNOWN, 1993
Bornova egitim ve arastirma bolgesi saglik ocaklarinda calisan saglik personelinin hepatit B ve C karsilasma yonunden arastirilmasi (Hepatitis B and C scereening among medical personnel in Bornova research center)
AUTHOR UNKNOWN, 1994
Hastane personelinde hepatit B seroprevalansi (Hepatitis B seroprevalence among medical personnel)
AUTHOR UNKNOWN, 1993
Cocuk hastanesi personeli hepatit B seroprevalansi (Hepatitis B prevalence among medical personnel in a childrens hospital)
AUTHOR UNKNOWN, 1994
Yuzuncu yil U. Tip fakultesi arastirma hastanesi personelinde hepatit B seroprevalansi (Hepatitis B seroprevalence among medical personnel in Yuzuncu yil university medical center)
AUTHOR UNKNOWN, 1995
Occupational exposure to hepatitis infection among Turkish nurses: frequency of needle exposure, sharps injuries and vaccination.
Kosgeroglu N, Ayranci U, Vardareli E, Dincer S., Epidemiol. Infect. 132(1), 2004
PMID: 14979586
Saglik calisanlarinda HB ve HC seroprevalansi (HBV and HCV prevalence among healthcare workers)
AUTHOR UNKNOWN, 2000
Ankara numune egitimi ve arastirma hastanesinde saglik calisanlarinda HBV enfeksiyonu (HBV infection among healtcare workers in Ankara numune research hospital)
AUTHOR UNKNOWN, 2001
Hasta bakim ve hastane hijyeniniden sorumlu saglik personelinde HBV, HCV ve HIV sikligi (HBV, HCV and HIV prevalence among personel responsible for patient care and hygiene)
AUTHOR UNKNOWN, 2003
Saglik personelinin HBV ile karsilasma orani (The chances of medical personal coming in contact with HBV)
AUTHOR UNKNOWN, 2002
Yeni kurulan bir Tip fakultesi hastanesinde saglik calisanlarinin hepatit B ve C seroprevalansi (Hepatitis B and C seroprevance among healthcare workers in a new builth university hospital)
AUTHOR UNKNOWN, 2003
Ataturk U. Dis hekimlige calisanlarinin hepatit B ve C yonunden incelenmesi (Hepatitis B and C screening among dentists in Ataturk university)
AUTHOR UNKNOWN, 2000
Saglik calisanlarinda viral hepatit A, B ve C seroprevalansi (Viral hepatitis A, B and C seroprevalence among medical personnel)
AUTHOR UNKNOWN, 2003
Hastane sağlık çalışanlarında HBV ve HCV serolojik belirteçlerinin prospektif taranması ve proflaktik aşı uygulanması (Prospective screening of HBV and HCV serologic markers and vaccination of healthcare workers in hospital)
AUTHOR UNKNOWN, 2005
Dis hekimliginde hepatit B prevalansi (Hepatitis B prevalence in dentistry)
AUTHOR UNKNOWN, 1991
Tip ogrencileri ve saglik personelinde HbsAg ve anti-HBs pozitifligi (HBsAg and anti-HBs positivity among medical students and personnel)
AUTHOR UNKNOWN, 1995
Tip ve dis hekimligi ogrencilerinde HbsAg arastirmasi (HBsAg screening among medical and dentistry students)
AUTHOR UNKNOWN, 1992
Hepatitis A and B seropositivity among medical students.
Oncu S, Oncu S, Sakarya S., Health Policy 74(1), 2005
PMID: 16098410
Prevalence of hepatitis B and C virus infection in barbers in the Sivas region of Turkey.
Candan F, Alagozlu H, Poyraz O, Sumer H., Occup Med (Lond) 52(1), 2002
PMID: 11872792
İzmir'deki çöp işçilerinde hepatit B, C ve E virusu seroprevalansı (Hepatitis B, C and E seroprevalence in garbagemen in İzmir)
AUTHOR UNKNOWN, 2004
Diyarbakir'da genel kadin, pavyonda calisan kadin ve dusuk sosyoekenomik duzeyindeki kadinlarda HbsAg, anti-HBs, anti-HCV prevalenasi (HBsAg, anti-HBs and anti-HCV prevalence among female sex workers and women in low socioeconomical status)
AUTHOR UNKNOWN, 2001
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.
Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative., PLoS Med. 4(10), 2007
PMID: 17941715
Hepatitis B and measles seroprevalence among Turkish children.
Kanra G, Tezcan S, Badur S; Turkish National Study Team., Turk. J. Pediatr. 47(2), 2005
PMID: 16052847
Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States.
Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ., Arch. Intern. Med. 157(22), 1997
PMID: 9531229
Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
Toy M, Veldhuijzen IK, de Man RA, Richardus JH, Schalm SW., Hepatology 50(3), 2009
PMID: 19585616
The Burden of chronic hepatitis B in a median endemic country; a mathematical approach
AUTHOR UNKNOWN, 2009
The importance of imported infections in maintaining hepatitis B in The Netherlands.
Veldhuijzen IK, Smits LJ, van de Laar MJ., Epidemiol. Infect. 133(1), 2005
PMID: 15724718
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Cornberg M., J. Hepatol. 52(4), 2010
PMID: 20207438
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 22151620
PubMed | Europe PMC

Suchen in

Google Scholar